Skip to main content
Clinical Trials/NCT01622816
NCT01622816CompletedNot Applicable

Prospective Determination of Agreement Between Standard ETDRS (Early Treatment Diabetic Retinopathy Study) Chart and Handheld Illuminated ETDRS Equivalent Chart in Eyes With Retinal Pathology

Julia Haller1 site in 1 country70 target enrollmentStarted: March 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
ETDRS Letter Score

Study Overview

Brief Summary

Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart

Detailed Description

Prospective determination of agreement between standard ETDRS chart and handheld illuminated ETDRS equivalent chart in eyes with retinal pathology

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study (one visit per patient).
  • Age greater than 18 years.
  • Clinical diagnosis of retinal disease (including age-related macular degeneration, macular degeneration, retinal vessel occlusion, among others).

Exclusion Criteria

  • Presence of a significant cataract as determined by your doctor.
  • Presence of a significant posterior capsular opacity (haziness in your eyes) as determined by your doctor.
  • Diagnosis of uveitis (inflammation in part of the eye).

Outcomes

Primary Outcomes

ETDRS Letter Score

Time Frame: 1 Day

To determine the visual acuity measurement using this handheld internally illuminated ETDRS chart, and a standard back illuminated EDTRS chart. This will be done during the visual acuity test.

Secondary Outcomes

  • ETDRS Letter Score Consistency(1 Day)

Investigators

Sponsor
Julia Haller
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Julia Haller

Investigator

Wills Eye

Study Sites (1)

Loading locations...

Similar Trials